No, Semaglutide and Tirzepatide are not a type of insulin or substitute for insulin. They do stimulate your pancreas to release insulin when glucose (sugar) is present. Because they both rely upon your body's own insulin to have this effect, neither Semaglutide nor Tirzepatide are used when your pancreas can't make insulin, such as in patients with type-1 diabetes.
No, Semaglutide and Tirzepatide are not a stimulant. While other weight loss medications, like phentermine, have stimulating effects that help curb your appetite, Semaglutide and Tirzepatide work differently (see above).
Yes. Semaglutide and Tirzepatide are considered to be safe and effective when used as indicated. However, safe doesn't mean there aren't risks. They also carries a boxed warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans). They shouldn't be used if you or your family have a history of certain thyroid cancers. They should not be used in people with type-1 diabetes or a history of pancreatitis.
They also should be used cautiously for people on other blood sugar lowering medications.
The common side effects of are:
This website uses cookies. By continuing to use this site, you accept our use of cookies.